Company description

Recipharm is a leading contract development and manufacturing organisation (CDMO) headquartered in Stockholm, Sweden. We operate development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and are continuing to grow and expand our offering for our customers. Employing around 6,000 people, we are focused on supporting pharmaceutical companies with our full service offering, taking products from early development through to commercial production. For over 20 years we have been there for our clients throughout the entire product lifecycle, providing pharmaceutical expertise and managing complexity, time and time again. Despite our growing global footprint, we conduct our business as we always have and continue to deliver value for money with each customer’s needs firmly at the heart of all that we do. That’s the Recipharm way. For more information visit www.recipharm.com

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Formulation development |Custom Manufacturing |Contract Services - Contract Services More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 121D32 See our Exhibitor Profile   See full Exhibitor List
9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 3D50 See our Exhibitor Profile   See full Exhibitor List
24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 41K10 See our Exhibitor Profile   See full Exhibitor List

News about Recipharm

Recipharm joins the AMR Industry Alliance

15 Nov 2019

Recipharm joins the AMR Industry Alliance

Marks the latest step in the company’s ongoing efforts to engage with other organisations working to tackle antimicrobial resistance.

Read more

7 Nov 2019

Recipharm expands Indian injectable dosage form capabilities

Partnership will combine capabilities and expertise in Europe and India to build a new facility dedicated to injectable formulations to supply demand from Europe and overseas territories.

Read more

1 Nov 2019

Recipharm launches new service to support companies with QC and analytical requirements

Services including method development, method validation, and stability program design and implementation.

Read more

7 May 2019

Recipharm launches its end-to-end inhalation offering

Offers a seamless outsourcing service for inhalation products, including MDIs, DPIs and nasal sprays.

Read more

Contact information




View all contact information